{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:07:22Z","timestamp":1768349242065,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,12,8]],"date-time":"2024-12-08T00:00:00Z","timestamp":1733616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,8]],"date-time":"2024-12-08T00:00:00Z","timestamp":1733616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National High-Level Hospital Clinical Research Funding","award":["2022-PUMCH-A-018"],"award-info":[{"award-number":["2022-PUMCH-A-018"]}]},{"name":"National High-Level Hospital Clinical Research Funding","award":["2022-PUMCH-C-043"],"award-info":[{"award-number":["2022-PUMCH-C-043"]}]},{"name":"Beijing Natural Science Foundation","award":["J20010"],"award-info":[{"award-number":["J20010"]}]},{"name":"Special Research Fund for Central Universities, Peking Union Medical College","award":["2022-I2M-C&T-B-065"],"award-info":[{"award-number":["2022-I2M-C&T-B-065"]}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2022YFC2407404"],"award-info":[{"award-number":["2022YFC2407404"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science & Technology Commission","doi-asserted-by":"crossref","award":["Z211100002921058"],"award-info":[{"award-number":["Z211100002921058"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Beijing Hope Run Special Fund of Cancer Foundation of China","award":["LC2021L01"],"award-info":[{"award-number":["LC2021L01"]}]},{"name":"Beijing Hope Run Special Fund of Cancer Foundation of China","award":["LC2021B12"],"award-info":[{"award-number":["LC2021B12"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1245\/s10434-024-16620-y","type":"journal-article","created":{"date-parts":[[2024,12,8]],"date-time":"2024-12-08T21:15:51Z","timestamp":1733692551000},"page":"3138-3146","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Outcomes of Intraoperative Radiotherapy for Locally Advanced Adenocarcinoma of the Esophagogastric Junction After Neoadjuvant Therapy: A Single-Arm, Phase 1 Trial From\u00a0the Chinese National Cancer Center"],"prefix":"10.1245","volume":"32","author":[{"given":"Guochao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinfu","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lide","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,8]]},"reference":[{"key":"16620_CR1","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1053\/j.gastro.2022.05.054","volume":"163","author":"E Morgan","year":"2022","unstructured":"Morgan E, Soerjomataram I, Rumgay H, et al. The global landscape of esophageal squamous cell carcinoma and esophageal adenocarcinoma incidence and mortality in 2020 and projections to 2040: new estimates from GLOBOCAN 2020. Gastroenterology. 2022;163:649-58.e642.","journal-title":"Gastroenterology."},{"key":"16620_CR2","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1136\/gutjnl-2020-321600","volume":"69","author":"M Arnold","year":"2020","unstructured":"Arnold M, Ferlay J, van Berge Henegouwen MI, Soerjomataram I. Global burden of oesophageal and gastric cancer by histology and subsite in 2018. Gut. 2020;69:1564\u201371.","journal-title":"Gut."},{"key":"16620_CR3","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/ajg.2017.155","volume":"112","author":"M Arnold","year":"2017","unstructured":"Arnold M, Laversanne M, Brown LM, Devesa SS, Bray F. Predicting the future burden of esophageal cancer by histological subtype: international trends in incidence up to 2030. Am J Gastroenterol. 2017;112:1247\u201355.","journal-title":"Am J Gastroenterol."},{"key":"16620_CR4","first-page":"124","volume":"1","author":"A Dubecz","year":"2013","unstructured":"Dubecz A, Solymosi N, Stadlhuber RJ, Schweigert M, Stein HJ, Peters JH. Does the incidence of adenocarcinoma of the esophagus and gastric cardia continue to rise in the twenty-first century? A SEER database analysis. J Gastrointest Surg. 2013;1:124\u20139.","journal-title":"J Gastrointest Surg."},{"key":"16620_CR5","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1111\/j.1440-1746.2008.05572.x","volume":"23","author":"C Kusano","year":"2008","unstructured":"Kusano C, Gotoda T, Khor CJ, et al. Changing trends in the proportion of adenocarcinoma of the esophagogastric junction in a large tertiary referral center in Japan. J Gastroenterol Hepatol. 2008;23:1662\u20135.","journal-title":"J Gastroenterol Hepatol."},{"key":"16620_CR6","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1007\/s00535-019-01577-7","volume":"54","author":"K Matsuno","year":"2019","unstructured":"Matsuno K, Ishihara R, Ohmori M, et al. Time trends in the incidence of esophageal adenocarcinoma, gastric adenocarcinoma, and superficial esophagogastric junction adenocarcinoma. J Gastroenterol. 2019;54:784\u201391.","journal-title":"J Gastroenterol."},{"key":"16620_CR7","doi-asserted-by":"crossref","first-page":"e943","DOI":"10.1016\/S2468-2667(23)00211-6","volume":"8","author":"J Qi","year":"2023","unstructured":"Qi J, Li M, Wang L, et al. National and subnational trends in cancer burden in China, 2005\u201320: an analysis of national mortality surveillance data. Lancet Public Health. 2023;8:e943\u201355.","journal-title":"Lancet Public Health."},{"key":"16620_CR8","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1002\/ijc.34417","volume":"152","author":"T Boerner","year":"2023","unstructured":"Boerner T, Carr RA, Hsu M, et al. Incidence and management of esophageal cancer recurrence to regional lymph nodes after curative esophagectomy. Int J Cancer. 2023;152:2109\u201322.","journal-title":"Int J Cancer."},{"key":"16620_CR9","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1200\/JCO.2011.39.1953","volume":"30","author":"J Lee","year":"2012","unstructured":"Lee J, Lim DH, Kim S, et al. Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial. J Clin Oncol. 2012;30:268\u201373.","journal-title":"J Clin Oncol."},{"key":"16620_CR10","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S1470-2045(18)30132-3","volume":"19","author":"A Cats","year":"2018","unstructured":"Cats A, Jansen EPM, van Grieken NCT, et al. Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial. Lancet Oncol. 2018;19:616\u201328.","journal-title":"Lancet Oncol."},{"key":"16620_CR11","volume":"370","author":"JS Vaidya","year":"2020","unstructured":"Vaidya JS, Bulsara M, Baum M, et al. Long-term survival and local control outcomes from single-dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT: a randomised clinical trial. BMJ. 2020;370:m2836.","journal-title":"BMJ."},{"key":"16620_CR12","first-page":"74","volume":"108","author":"P Gao","year":"2017","unstructured":"Gao P, Tsai C, Yang Y, et al. Intraoperative radiotherapy in gastric and esophageal cancer: meta-analysis of long-term outcomes and complications. Minerva Med. 2017;108:74\u201383.","journal-title":"Minerva Med."},{"key":"16620_CR13","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.ijrobp.2008.03.012","volume":"72","author":"S Fu","year":"2008","unstructured":"Fu S, Lu JJ, Zhang Q, Yang Z, Peng L, Xiong F. Intraoperative radiotherapy combined with adjuvant chemoradiotherapy for locally advanced gastric adenocarcinoma. Int J Radiat Oncol Biol Phys. 2008;72:1488\u201394.","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"16620_CR14","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3349\/ymj.2022.63.5.405","volume":"63","author":"Y Cho","year":"2022","unstructured":"Cho Y, Kim JW, Kim HS, Park JS, Lee IJ. Intraoperative radiotherapy for resectable pancreatic cancer using a low-energy x-ray source: postoperative complications and early outcomes. Yonsei Med J. 2022;63:405\u201312.","journal-title":"Yonsei Med J."},{"key":"16620_CR15","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1002\/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C","volume":"73","author":"AM Mandard","year":"1994","unstructured":"Mandard AM, Dalibard F, Mandard JC, et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma: clinicopathologic correlations. Cancer. 1994;73:2680\u20136.","journal-title":"Cancer."},{"key":"16620_CR16","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/SLA.0000000000001098","volume":"262","author":"DE Low","year":"2015","unstructured":"Low DE, Alderson D, Cecconello I, et al. International consensus on standardization of data collection for complications associated with esophagectomy: Esophagectomy Complications Consensus Group (ECCG). Ann Surg. 2015;262:286\u201394.","journal-title":"Ann Surg."},{"key":"16620_CR17","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13014-016-0753-0","volume":"12","author":"R Krempien","year":"2017","unstructured":"Krempien R, Roeder F. Intraoperative radiation therapy (IORT) in pancreatic cancer. Radiat Oncol. 2017;12:8.","journal-title":"Radiat Oncol."},{"key":"16620_CR18","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.radonc.2008.07.020","volume":"91","author":"V Valentini","year":"2009","unstructured":"Valentini V, Calvo F, Reni M, et al. Intra-operative radiotherapy (IORT) in pancreatic cancer: joint analysis of the ISIORT-Europe experience. Radiother Oncol. 2009;91:54\u20139.","journal-title":"Radiother Oncol."},{"key":"16620_CR19","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1053\/ejso.2000.1002","volume":"26","author":"VY Skoropad","year":"2000","unstructured":"Skoropad VY, Berdov BA, Mardynski YS, Titova LN. A prospective, randomized trial of pre-operative and intraoperative radiotherapy versus surgery alone in resectable gastric cancer. Eur J Surg Oncol. 2000;26:773\u20139.","journal-title":"Eur J Surg Oncol."},{"key":"16620_CR20","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/jrr\/rrs045","volume":"53","author":"Y Tamaki","year":"2012","unstructured":"Tamaki Y, Sasaki R, Ejima Y, et al. Efficacy of intraoperative radiotherapy targeted to the abdominal lymph node area in patients with esophageal carcinoma. J Radiat Res. 2012;53:882\u201391.","journal-title":"J Radiat Res."},{"key":"16620_CR21","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1245\/s10434-012-2810-8","volume":"20","author":"FA Calvo","year":"2013","unstructured":"Calvo FA, Sole CV, Obreg\u00f3n R, et al. Postchemoradiation resected locally advanced esophageal and gastroesophageal junction carcinoma: long-term outcome with or without intraoperative radiotherapy. Ann Surg Oncol. 2013;20:1962\u20139.","journal-title":"Ann Surg Oncol."},{"key":"16620_CR22","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1046\/j.1442-2050.1999.00050.x","volume":"12","author":"M Murakami","year":"1999","unstructured":"Murakami M, Kuroda Y, Nakajima T, et al. Intraoperative radiotherapy for the abdominal lymphatic system in patients with esophageal carcinoma. Dis Esophagus. 1999;12:270\u20135.","journal-title":"Dis Esophagus."},{"key":"16620_CR23","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1442-2050.2006.00626.x","volume":"19","author":"RC Miller","year":"2006","unstructured":"Miller RC, Haddock MG, Gunderson LL, et al. Intraoperative radiotherapy for treatment of locally advanced and recurrent esophageal and gastric adenocarcinomas. Dis Esophagus. 2006;19:487\u201395.","journal-title":"Dis Esophagus."},{"key":"16620_CR24","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1200\/JCO.20.03614","volume":"39","author":"BM Eyck","year":"2021","unstructured":"Eyck BM, van Lanschot JJB, Hulshof M, et al. Ten-year outcome of neoadjuvant chemoradiotherapy plus surgery for esophageal cancer: the randomized controlled CROSS trial. J Clin Oncol. 2021;39:1995\u20132004.","journal-title":"J Clin Oncol."},{"key":"16620_CR25","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1001\/jamasurg.2021.2373","volume":"156","author":"H Yang","year":"2021","unstructured":"Yang H, Liu H, Chen Y, et al. Long-term efficacy of neoadjuvant chemoradiotherapy plus surgery for the treatment of locally advanced esophageal squamous cell carcinoma: the NEOCRTEC5010 randomized clinical trial. JAMA Surg. 2021;156:721\u20139.","journal-title":"JAMA Surg."},{"key":"16620_CR26","doi-asserted-by":"crossref","first-page":"1206504","DOI":"10.3389\/fimmu.2023.1206504","volume":"14","author":"Y Wang","year":"2023","unstructured":"Wang Y, Yang W, Wang Q, Zhou Y. Mechanisms of esophageal cancer metastasis and treatment progress. Front Immunol. 2023;14:1206504.","journal-title":"Front Immunol."},{"key":"16620_CR27","doi-asserted-by":"crossref","first-page":"4091","DOI":"10.1038\/s41467-021-24386-0","volume":"12","author":"YF Sun","year":"2021","unstructured":"Sun YF, Wu L, Liu SP, et al. Dissecting spatial heterogeneity and the immune-evasion mechanism of CTCs by single-cell RNA-seq in hepatocellular carcinoma. Nat Commun. 2021;12:4091.","journal-title":"Nat Commun."},{"key":"16620_CR28","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ccell.2023.01.001","volume":"41","author":"X Liu","year":"2023","unstructured":"Liu X, Song J, Zhang H, et al. Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillance. Cancer Cell. 2023;41:272-7.e279.","journal-title":"Cancer Cell."},{"key":"16620_CR29","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.jtcvs.2023.08.056","volume":"167","author":"Y Yang","year":"2024","unstructured":"Yang Y, Liu J, Liu Z, et al. Two-year outcomes of clinical N2\u20133 esophageal squamous cell carcinoma after neoadjuvant chemotherapy and immunotherapy from the phase 2 NICE study. J Thorac Cardiovasc Surg. 2024;167:838-47.e831.","journal-title":"J Thorac Cardiovasc Surg."},{"key":"16620_CR30","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S1470-2045(23)00541-7","volume":"25","author":"K Shitara","year":"2024","unstructured":"Shitara K, Rha SY, Wyrwicz LS, et al. Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study. Lancet Oncol. 2024;25:212\u201324.","journal-title":"Lancet Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-16620-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-024-16620-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-16620-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T06:18:48Z","timestamp":1744093128000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-024-16620-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,8]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["16620"],"URL":"https:\/\/doi.org\/10.1245\/s10434-024-16620-y","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,8]]},"assertion":[{"value":"20 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}